Evidence map›Paper›PMID 32832083›Full record

ArticleMolecular and clinical oncology2020

Diagnosis and treatment of a rare tumor-bladder paraganglioma.

Hang Li, Jiaodi Xie, Zebo Chen, Shangqi Yang, Yongqing Lai

Open access · diamondAbstract read
In one paragraph

Article in Molecular and clinical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. URINARY BLADDER PARAGANGLIOMA- A NOTEWORTHY, RARE ENTITY.Acta endocrinologica (Bucharest, Romania : 2005)
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Hang LiDepartment of Urology, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST (Peking University, Hong Kong University of Science and Technology) Medical Center, Shenzhen, Guangdong 518036, P.R. China.
Jiaodi XieDepartment of Urology, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST (Peking University, Hong Kong University of Science and Technology) Medical Center, Shenzhen, Guangdong 518036, P.R. China.
Zebo ChenDepartment of Urology, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST (Peking University, Hong Kong University of Science and Technology) Medical Center, Shenzhen, Guangdong 518036, P.R. China.
Shangqi YangDepartment of Urology, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST (Peking University, Hong Kong University of Science and Technology) Medical Center, Shenzhen, Guangdong 518036, P.R. China.
Yongqing LaiDepartment of Urology, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST (Peking University, Hong Kong University of Science and Technology) Medical Center, Shenzhen, Guangdong 518036, P.R. China.
University of Hong Kong - Shenzhen Hospital · CNHong Kong University of Science and Technology · HKPeking University Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder paragangliomas are very rare tumors that are often misdiagnosed. The present study retrospectively analyzed the clinical data and follow-up results of patients with bladder paraganglioma that were treated surgically in Peking University Shenzhen Hospital between 2012 and 2018, and reviewed the relevant literature. A total of 4 patients with bladder paraganglioma were treated surgically from 2012 to 2018. All patients were female with ages ranging from 28 to 54 years old (average, 47.25). A total of one patient exhibited micturition attacks and palpitations, and one other exhibited gross hematuria. A total of two patients exhibited while no obvious symptoms. One patient exhibited elevated plasma catecholamine, was well prepared with medicine and underwent partial cystectomy, and 3 patients were not successfully diagnosed with paraganglioma before surgery. These patients received transurethral resection and 2 had distinct blood pressure elevation during operation. After surgery, the patients were followed-up for 5-69 months, during which all had normal blood pressure and none experienced recurrence. Bladder paragangliomas exhibit a variety of clinical presentations, which can be nonspecific for the non-functional ones, therefore may easily lead to misdiagnosis. Surgeons must fully consider the possibility of this disease when dealing with non-epithelial bladder tumors. Surgical resection is an effective treatment. For cases successfully diagnosed before surgery, partial cystectomy should be a treatment priority.

Indexed as

bladder tumordiagnosisimmunohistochemistryparagangliomatreatment

Identifiers

PMID32832083
PMCPMC7439150
OpenAlexW3048677843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.